J Wodniecki

873 total citations
34 papers, 633 citations indexed

About

J Wodniecki is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, J Wodniecki has authored 34 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in J Wodniecki's work include Coronary Interventions and Diagnostics (5 papers), Cardiomyopathy and Myosin Studies (5 papers) and Pulmonary Hypertension Research and Treatments (4 papers). J Wodniecki is often cited by papers focused on Coronary Interventions and Diagnostics (5 papers), Cardiomyopathy and Myosin Studies (5 papers) and Pulmonary Hypertension Research and Treatments (4 papers). J Wodniecki collaborates with scholars based in Poland, United States and Hungary. J Wodniecki's co-authors include Celina Wojciechowska, Ewa Nowalany-Kozielska, Lech Poloński, Romuald Wojnicz, Marian Zembala, M. M. Rozek, Tomasz Niklewski, G Glanowska, Przemysław Wilczewski and Michał Tendera and has published in prestigious journals such as Circulation, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

J Wodniecki

32 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Wodniecki Poland 9 469 171 108 75 67 34 633
Mototsugu Nishii Japan 15 367 0.8× 102 0.6× 86 0.8× 57 0.8× 14 0.2× 30 581
Jean René Lusson France 11 164 0.3× 113 0.7× 67 0.6× 49 0.7× 112 1.7× 34 403
Joseph B. Muhlestein United States 13 278 0.6× 285 1.7× 193 1.8× 118 1.6× 23 0.3× 26 620
Marco Mettimano Italy 10 146 0.3× 143 0.8× 51 0.5× 63 0.8× 33 0.5× 24 395
James S. Zebrack United States 7 241 0.5× 199 1.2× 208 1.9× 87 1.2× 17 0.3× 10 467
Hale Yılmaz Türkiye 14 276 0.6× 159 0.9× 68 0.6× 26 0.3× 18 0.3× 41 482
Jesús Castillo Spain 13 194 0.4× 103 0.6× 522 4.8× 36 0.5× 56 0.8× 26 872
L. Joost van Pelt Netherlands 12 142 0.3× 121 0.7× 97 0.9× 90 1.2× 15 0.2× 22 520
Harry Yu United States 8 96 0.2× 124 0.7× 132 1.2× 62 0.8× 38 0.6× 9 373
Namık Özmen Türkiye 11 202 0.4× 74 0.4× 53 0.5× 27 0.4× 22 0.3× 44 372

Countries citing papers authored by J Wodniecki

Since Specialization
Citations

This map shows the geographic impact of J Wodniecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Wodniecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Wodniecki more than expected).

Fields of papers citing papers by J Wodniecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Wodniecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Wodniecki. The network helps show where J Wodniecki may publish in the future.

Co-authorship network of co-authors of J Wodniecki

This figure shows the co-authorship network connecting the top 25 collaborators of J Wodniecki. A scholar is included among the top collaborators of J Wodniecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Wodniecki. J Wodniecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wojciechowska, Celina, J Wodniecki, Romuald Wojnicz, et al.. (2014). Neopterin and Beta-2 Microglobulin Relations to Immunity and Inflammatory Status in Nonischemic Dilated Cardiomyopathy Patients. Mediators of Inflammation. 2014. 1–8. 10 indexed citations
2.
Wojnicz, Romuald, Krzysztof Wilczek, Ewa Nowalany-Kozielska, et al.. (2006). Usefulness of Atorvastatin in Patients With Heart Failure Due to Inflammatory Dilated Cardiomyopathy and Elevated Cholesterol Levels. The American Journal of Cardiology. 97(6). 899–904. 85 indexed citations
3.
Wojnicz, Romuald, Jolanta Nowak, Bożena Szyguła‐Jurkiewicz, et al.. (2006). Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: One-year follow-up results of the randomized trial. American Heart Journal. 152(4). 713.e1–713.e7. 13 indexed citations
4.
Kasperczyk, Sławomir, et al.. (2005). Function of heart muscle in people chronically exposed to lead.. PubMed. 12(2). 207–10. 21 indexed citations
5.
Wodniecki, J, et al.. (2005). [Sildenafil reduces pressure and pulmonary resistance and increases susceptibility of pulmonary arteries to nitric oxide in primary pulmonary arterial hypertension].. PubMed. 62(2). 135–8. 2 indexed citations
6.
Jacheć, Wojciech, Andrzej Tomasik, Stanisław Woś, et al.. (2003). Lipid peroxidation and vitamin E in human coronary atherosclerotic lesions. Clinica Chimica Acta. 330(1-2). 121–129. 5 indexed citations
7.
Walichiewicz, Piotr, Krzysztof Wilczek, Wojciech Jacheć, et al.. (2003). Post-Dilatation Intravascular Brachytherapy Trials on Hypercholesterolemic Rabbits Using 32P-Phosphate Solutions in Angioplasty Balloons. CardioVascular and Interventional Radiology. 27(1). 42–50. 3 indexed citations
8.
Tomasik, Andrzej, et al.. (2003). Circulating electronegatively charged low‐density lipoprotein in patients with angiographically documented coronary artery disease. Scandinavian Journal of Clinical and Laboratory Investigation. 63(4). 259–266. 15 indexed citations
9.
Walichiewicz, Piotr, Krzysztof Wilczek, Wojciech Jacheć, et al.. (2003). 32P liquid sources—comparison of the effectiveness of postangioplasty versus poststenting intravascular brachytherapy in hypercholesterolemic rabbits. PubMed. 4(2). 64–68. 3 indexed citations
10.
Romuk, Ewa, Celina Wojciechowska, Andrzej Tomasik, et al.. (2002). Selectin‐P and interleukin‐8 plasma levels in coronary heart disease patients. European Journal of Clinical Investigation. 32(9). 657–661. 64 indexed citations
11.
Wilczek, Krzysztof, Piotr Walichiewicz, Wojciech Jacheć, et al.. (2002). Post-stenting Intravascular Brachytherapy Trials on Hypercholesterolemic Rabbits Using 32P Liquid Sources: Implications for Prevention of In-Stent Restenosis. CardioVascular and Interventional Radiology. 25(4). 307–313. 3 indexed citations
12.
Wodniecki, J, et al.. (2002). [The whole blood and plasma viscosity changes in course of acute myocardial infarction].. PubMed. 108(4). 971–8. 8 indexed citations
13.
Bilski, P., et al.. (2000). Thermoluminescence dosimetry in evaluation of liquid 32P sources for intravascular brachytherapy. Radiation Measurements. 32(3). 205–210. 5 indexed citations
14.
Wodniecki, J, et al.. (1999). [Troponin T--is it a marker of restenosis after transluminal percutaneous angioplasty in unstable angina patients?].. PubMed. 101(1). 33–7. 2 indexed citations
15.
Walichiewicz, Piotr, et al.. (1998). [Use of fourier row as a method for analyzing the course of circadian heart rate in patients with left ventricular ejection fraction impairment].. PubMed. 99(6). 477–86.
16.
17.
Tendera, Michał, et al.. (1993). Effect of Sotalol on Arrhythmias and Exercise Tolerance in Patients with Hypertrophic Cardiomyopathy. Cardiology. 82(5). 335–342. 47 indexed citations
18.
Tendera, Michał, et al.. (1991). Evolution of the electrocardiographic changes in patients with hypertrophic cardiomyopathy. Clinical Cardiology. 14(11). 891–896. 1 indexed citations
19.
Tendera, Michał, et al.. (1986). [Aortic arch anomaly of the "kinking" type. Clinical and radiologic evaluation].. PubMed. 50(1). 13–8. 1 indexed citations
20.
Wodniecki, J, et al.. (1967). [Clinical analysis of 20 cases of multiple myeloma].. PubMed. 20(7). 641–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mototsugu Nishii Breakdown of academic impact, for papers by Jean René Lusson Breakdown of academic impact, for papers by Joseph B. Muhlestein Breakdown of academic impact, for papers by Marco Mettimano Breakdown of academic impact, for papers by James S. Zebrack Breakdown of academic impact, for papers by Hale Yılmaz Breakdown of academic impact, for papers by Jesús Castillo Breakdown of academic impact, for papers by L. Joost van Pelt Breakdown of academic impact, for papers by Harry Yu Breakdown of academic impact, for papers by Namık Özmen
Rankless by CCL
2026